Search Results

Endovascular Repair of Blunt Aortic Injury

Blunt aortic injury (BAI) occurs in approximately 0.3% of all trauma patients who survive to emergency department presentation and is the second leading cause of trauma-related deaths, with an estimated 8,000 deaths per year.

FDA Expands IDE for Starnes' Study of Fenestrated EVAR

September 9, 2015—Aortica Corporation, an early stage private company founded by Benjamin W. Starnes, MD, Chief of Vascular Surgery at Harborview Medical Center in Seattle, Washington, announced that Dr. Starnes has received US Food and Drug Administration (FDA) approval to expand his physician-sponsored investigational device exemption (IDE) study. The IDE is designed to assess a new technology that seeks to significantly reduce the need for invasive open surgery in patients with abdominal aortic aneurysms (AAAs) in close proximity to (or encompassing) branch arteries. The study is being administered in conjunction with Harborview Medical Center. 

Aortica's FEVAR Case-Planning Software Used for Physician-Modified Grafts to Treat Juxtarenal AAA

February 28, 2017—Benjamin W. Starnes, MD, Chief of Vascular Surgery at the University of Washington in Seattle, Washington, recently announced midterm results from an ongoing physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts (PMEGs) for the treatment of juxtarenal abdominal aortic aneurysms (AAAs) in patients who are deemed unfit for open repair. The study, which is administered in conjunction with Harborview Medical Center in Seattle, was published by Dr. Starnes et al in the Journal of Vascular Surgery (2017;65:294–302).

Midterm Results Reported for Physician-Modified Endovascular Grafts to Treat Juxtarenal Aortic Aneurysms

February 1, 2017—In the Journal of Vascular Surgery (JVS), Benjamin W. Starnes, MD, et al published the midterm results from an ongoing physician-sponsored investigational device exemption (IDE) clinical trial evaluating physician-modified endovascular grafts (PMEGs) for the treatment of juxtarenal aortic aneurysms in patients who are deemed unfit for open repair (2017;65:294–302).

Classification Scheme Developed for Blunt Aortic Injury Treatment

November 30, 2011—The Society for Vascular Surgery (SVS) announced that investigators at the University of Washington's Harborview Medical Center in Seattle developed a classification scheme for the treatment of blunt aortic injury (BAI).

Physician-Modified Endovascular Grafts Shown to Be Effective Treatment Option

June 17, 2011—The Society for Vascular Surgery announced that a new study shows that physician-modified endovascular grafts (PMEGs) are an effective method of treating juxtarenal aortic aneurysms in patients who are considered to be unsuitable for open surgical repair.